| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.2 |